Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
AbbVie
Kristian Reich; Henrique D Teixeira; Marjolein de Bruin-Weller; Thomas Bieber; Weily Soong; Kenji Kabashima; Thomas Werfel; Jiewei Zeng; Xiaohong Huang; Xiaofei Hu; Barbara A Hendrickson; Barry Ladizinski; Alvina D Chu; Jonathan I Silverberg